HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: The bias against diabetes

The latest Sun Life Financial Asia Diabetes Awareness Study reveals an alarming knowledge gap in diabetes. A third of Asian women who are or were pregnant in the past three years are unaware of the risk of developing gestational diabetes in pregnancy, while one in seven births in Asia is currently affected by gestational diabetes.

The prevalence of diabetes is a growing health challenge in the region. “Sun Life has commissioned study to demystify this chronic disease,” said Jeremy Young, chief marketing officer, Sun Life Financial Asia. “It aims to bridge the knowledge gap and promoting positive perception change towards diabetes, helping people live healthier lives – both physically and mentally, in addition to achieving lifetime financial security,”

Almost a third of respondents in the region do not even know there is more than one type of diabetes. Hong Kong, one of the most developed surveyed markets, sees the lowest level of awareness with 40% of respondents not knowing this fact, whereas the Philippines demonstrates a better basic understanding of diabetes, with 85% of respondents stating they are aware of the fact.

“As evidenced by Hong Kong people’s misunderstanding of diabetes, more efforts should be devoted to address the issue,” said Belinda Au, general manager of distribution and marketing, Sun Life Hong Kong.  “In Hong Kong, Sun Life has been partnering with diabetes organisations to educate the public on the disease and will continue to be committed in doing so to raise public awareness.”

The survey also finds that respondents believe diabetes decreases life expectancy by 19 years on average, when in fact, the average is between 10 and 12 years: a significant gap between perception and reality.

About half of the respondents from Vietnam, the Philippines and Hong Kong believe that diabetes represents a burden on public healthcare systems.

On average, respondents across the region estimate that a person with diabetes has to pay approximately US$1,778 for treatment every year. Hong Kong tops the list – with the estimate at approximately US$4,400 whereas the four southeast Asian markets record an average estimate of below US$1,120. When comparing the estimate with each market’s GDP per capita, Vietnam is the most extreme case where the cost estimate is more than half of its GDP per capita (approximately US$2,310) whereas the figure accounts for one tenth of Hong Kong’s GDP per capita – approximately US$45,000.

“The alarming prevalence of diabetes in Asia will continue to put economic burden on the public healthcare systems, as well as on diabetics and their families,” added Young.

The study reveals the public’s bias towards diabetics and strong associations with unfavourable characteristics, such as dangerous driving, laziness, lack of energy, not being athletic and having mood swings. Such stigma also exists in Hong Kong, where more than half of respondents think that diabetics are not energetic.

Au continued: “Social stigma towards diabetics adversely impacts the mental health and wellness of diabetics, yet it is often overlooked. With Sun Life’s purpose in helping people live healthier lives – both physically and mentally in addition to achieving lifetime financial security, we are keen to drive, and hopeful to see, positive perception change and reduce bias against diabetes.”

Posted on: 14/11/2017 UTC+08:00


Life sciences company OncoSil Medical is to raise A$18.7 million (US$14.4 million) in a two tranche institutional placement and share purchase plan.
Hong Kong listed hospital services company Hua Xia Healthcare has raised HK$46 million (US$5.9 million) in a private placement. Kingston Securities managed the deal.
AK Medical Holdings, which is the largest artificial orthopaedic joint manufacturer in China, has reported a 36.3% rise in profits for the year to Rmb105.4 million (US$16.7 million) on revenues that rose 37.6% to Rmb372.7 million.
Singapore-based DocDoc, a service which enables both locals and medical tourists to find a doctor or dentist across the region, has raised US$5.45 million in Series B funding. The financing is led by Adamas Finance Asia Limited (Adam), a London listed investment company which invested US$2 million via a convertible bond offering alongside regional family offices and high net worth individuals.
The owners of Australian health imaging company Pro Medicus have sold down significant stakes in the company.
IHH Healthcare, Asia’s largest healthcare company, has acquired a 60% stake in Chengdu Shenton Health Clinic, formerly known as Sincere Chengdu Clinic, from Beijing Yizhi Zhuoxin Corporate Management Information for Rmb12 million (US$1.9 million).
Japanese home care nursing group Longlife Holdings plans to set up a fee-based nursing home in Ikeda-shi, Osaka.
Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, has reported an 37.2% rise in annual profits to US$11 million on revenues that were up 15.9% to US$136.9 million.


Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.
It can sometimes seem that the healthcare sector is a guaranteed money spinner for investors. It has everything going for it. Societal demands and demographics make it a sure thing, say enthusiasts. And investors have become used to the fact that everything it touches turns to gold.
Yesterday’s stock price fall for Ramsay Health Care was not entirely unexpected. Shares in Australia’s largest private hospital operator dropped 5.75% to A$63.90 (US$49.81) after it revealed distinctly unimpressive first half figures.
Susann Roth, senior social development specialist, Asian Development Bank, gives one way how health risks can be lowered at Special Economic Zones.
Nicole Hill, global director of healthcare at ALE, has a goal to make everyone and everything in healthcare connected. She explains how healthcare is entering a second wave of digitisation in Asia.
There is a simple reason why healthcare stocks on the SGX rose today. Yesterday’s budget was focused firmly on healthcare. Finance minister Heng Swee Keat announced not just an additional S$10.2 billion (US$7.8 million) for healthcare over the next year, he made clear that he was committed to the sector.
A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices